Global EditionASIA 中文雙語Fran?ais
    World
    Home / World / World Watch

    China keeps promise to developing countries

    By Adhere Cavince | China Daily Global | Updated: 2021-02-22 10:45
    Share
    Share - WeChat
    A container transports first doses of the Sinovac Biotech coronavirus disease (COVID-19) vaccines upon their arrival at Benito Juarez International airport, as the coronavirus disease (COVID-19) outbreak continues, in Mexico City, Mexico on Feb 20, 2021. [Photo/Agencies]

    At the opening of the 73rd session of the World Health Organization's World Health Assembly in May last year, President Xi Jinping said that once COVID-19 vaccine development and deployment was completed in China, the vaccine would be made available as a global public good to developing countries.

    That promise is now becoming a reality, with more than 50 countries in Europe, Asia, Africa and the Americas having received purchases or donations of the essential commodity from Beijing.

    Vaccine access is deemed to be the most potent and sustainable way out of the global health crisis, yet it has remained unbalanced globally, with 10 rich economies taking up over 75 percent of the already administered COVID-19 vaccines. On the other hand, 130 countries have yet to receive a single dose of vaccine, according to United Nations Secretary-General Antonio Guterres.

    Thanks to its strong epidemic control experience and capacity, China is now sending more vaccines to other countries than is being administered domestically. This is a sharp contrast to countries that have engaged in vaccine nationalism, with some stocking up to four times more than they need. China's move thus responds to the WHO's long-standing call for able countries to support deprived economies in vaccinating front-line workers and vulnerable parts of their populations before embarking on mass vaccination campaigns.

    Due to constraints in cost and storage requirements for earlier vaccine candidates from Europe and the United States, African countries watched from the sidelines as other regions went into full vaccination mode. So the recent excitement that accompanied the delivery of 200,000 Sinopharm vaccine doses to Zimbabwe is therefore understandable. Through China's donation, Zimbabwe will inoculate all its front-line health workers, with the remaining doses covering vaccinations of vulnerable groups. Equatorial Guinea and Senegal have also received donated Sinopharm vaccine, while Sierra Leone is set to get vaccine from Beijing this month.

    China has also committed to supplying 10 million COVID-19 vaccine doses to meet the needs of developing economies through the WHO-led COVAX, a global initiative aimed at equitable access to the vaccines. This is in addition to the many bilateral deals that various countries are pursuing with regard to acquiring vaccines from Beijing.

    While China's promotion of vaccine access has been viewed by some Western countries as a pursuit of global influence, the ultimate impact of vaccine nationalism by the same accusers poses a far greater threat to the world's vulnerable.

    Data from the WHO indicates that COVID-19 deaths in Africa increased 40 percent in January this year compared with December last year, with a fatality rate of 2.6 percent, compared with the global average of 2.3 percent. New virus mutations with the ability to spread much faster are fueling a more dangerous second wave across the continent.

    Besides the earlier documented advantages of the Chinese vaccine candidates on the basis of storage requirements and cost, Beijing is now home to a single-dose vaccine with 65.7 percent effectiveness in preventing symptomatic cases and 90.1 percent efficacy against severe disease. In addition, the Sinovac Biotech vaccine has been found effective against the variants discovered in the UK and South Africa.

    In order to meet the increasing demand for vaccines around the world, China should ramp up production and distribution facilities and processes. The cold-chain air bridge between Shenzhen and Ethiopia, as well as alternate manufacturing hubs in Egypt and Morocco, will significantly aid African access to vaccines from China.

    While every government is racing to cushion its population and economy from the disease and its impacts, it is critical that no country or individual is left behind.

    The understanding that no part of the world will be safe as long as some pockets of the globe are under the spell of the virus should drive an even greater international response.

    The author is a Kenya-based international relations researcher with a focus on China-Africa relations. The views do not necessarily reflect those of China Daily.

    Most Viewed in 24 Hours
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    特级做A爰片毛片免费看无码| 久久亚洲精品无码AV红樱桃 | 亚洲va中文字幕无码久久不卡| 中文字幕日韩精品无码内射| 中文字幕乱码人妻无码久久| 免费人妻无码不卡中文字幕系| 国产高清中文欧美| 一本之道高清无码视频| 国产精品无码一区二区三级 | 亚洲Aⅴ无码专区在线观看q| 久久亚洲2019中文字幕| 99久久无色码中文字幕人妻| 97无码免费人妻超| 日韩精品中文字幕无码一区| 精品亚洲成在人线AV无码| 欧美日韩不卡一区二区三区中文字 | 国产日韩精品中文字无码| 天堂无码久久综合东京热| 国产精品无码不卡一区二区三区| 高潮潮喷奶水飞溅视频无码| 中文字幕一区在线观看视频| 中文字幕人妻无码系列第三区| 国产精品无码无卡无需播放器| 无码午夜人妻一区二区三区不卡视频 | 亚洲AV综合色区无码一区爱AV| 日本无码小泬粉嫩精品图| 国产成人无码AV麻豆| 高清无码午夜福利在线观看| 亚洲看片无码在线视频| 无码精品国产dvd在线观看9久| 一二三四在线播放免费观看中文版视频| 中文字幕精品亚洲无线码二区| 亚洲国产综合无码一区二区二三区 | 亚洲精品人成无码中文毛片 | 亚洲福利中文字幕在线网址| 在线日韩中文字幕| 免费精品久久久久久中文字幕| 日韩欧美一区二区三区中文精品| 亚洲天堂中文字幕在线| 人妻中文无码久热丝袜| 亚洲av无码一区二区乱子伦as|